Toronto Dominion Bank purchased a new stake in LAVA Medtech Acquisition Corp. (NASDAQ:LVAC – Get Rating) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 300,000 shares of the company's stock, valued at approximately $2,994,000. Toronto Dominion Bank owned approximately 2.09% of LAVA Medtech Acquisition at the end of the most recent reporting period.

A number of other institutional investors have also recently modified their holdings of the business. Beryl Capital Management LLC purchased a new stake in shares of LAVA Medtech Acquisition in the fourth quarter valued at approximately $9,890,000. Saba Capital Management L.P. purchased a new stake in LAVA Medtech Acquisition during the fourth quarter worth $5,329,000. Wolverine Asset Management LLC purchased a new stake in LAVA Medtech Acquisition during the fourth quarter worth $3,047,000. Oaktree Capital Management LP purchased a new stake in LAVA Medtech Acquisition during the fourth quarter worth $2,500,000. Finally, Radcliffe Capital Management L.P. purchased a new stake in LAVA Medtech Acquisition during the fourth quarter worth $1,000,000. 31.65% of the stock is currently owned by hedge funds and other institutional investors.

LAVA Medtech Acquisition Stock Performance

LVAC opened at $10.07 on Wednesday. The business's fifty day moving average is $10.01 and its two-hundred day moving average is $9.98. LAVA Medtech Acquisition Corp. has a one year low of $9.83 and a one year high of $10.07.

About LAVA Medtech Acquisition

LAVA Medtech Acquisition Corp. does not have significant operations. It intends to acquire assets and businesses through a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization. The company focuses on pursuing opportunities in healthcare and healthcare-related industries.

Read More

• Get a free copy of the StockNews.com research report on LAVA Medtech Acquisition (LVAC)
• Are These 3 Video Game Stocks Now In Play?
• 2 Long-Term EV Plays Trading Under $20
• Why Apple is Primed to Take a Bite Out of Live Sports
• Exxon, Occidental Petroleum Lead Heavy Month Of Insider Buying
• Home Depot Results Point To Sluggish 2nd Half

Want to see what other hedge funds are holding LVAC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LAVA Medtech Acquisition Corp. (NASDAQ:LVAC – Get Rating).

Receive News & Ratings for LAVA Medtech Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LAVA Medtech Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.